Ifp Advisors, Inc Compass Pathways PLC Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	N/A	-125 Reduced 92.59%	10 $0
Q1 2023 Apr 18, 2023	SELL	$7.32 - $10.85 $417 - $618	-57 Reduced 29.69%	135 $1,000
Q4 2022 Feb 07, 2023	SELL	$7.84 - $11.68 $2,430 - $3,620	-310 Reduced 61.75%	192 $7,000
Q2 2022 Sep 06, 2022	BUY	$6.76 - $14.18 $3,393 - $7,118	502 New	502 $16,000
Q2 2022 Aug 12, 2022	SELL	$6.76 - $14.18 $3,393 - $7,118	-502 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$11.13 - $23.04 $1,302 - $2,695	117 Added 30.39%	502 $6,000
Q4 2021 Jan 12, 2022	BUY	$21.81 - $48.96 $218 - $489	10 Added 2.67%	385 $10,000
Q2 2021 Jul 13, 2021	BUY	$32.29 - $39.68 $8,072 - $9,920	250 Added 200.0%	375 $15,000
Q1 2021 Apr 30, 2021	BUY	$34.75 - $57.5 $4,343 - $7,187	125 New	125 $5,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.